Stock A238120 ALIGNED GENETICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Aligned Genetics, Inc.

Equities

A238120

KR7238120000

Advanced Medical Equipment & Technology

End-of-day quote Korea S.E.
Other stock markets
 18:00:00 2024-05-02 EDT 		5-day change 1st Jan Change
4,445 KRW -0.34% Intraday chart for Aligned Genetics, Inc. -1.00% +10.30%
2016 Logos Biosystems, Inc. has completed an IPO in the amount of KRW 18.056448 billion. CI
2016 Logos Biosystems, Inc. has filed an IPO. CI

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 47,091 48,709 71,176 61,614 54,137 57,947
Enterprise Value (EV) 1 33,238 36,090 60,165 52,912 44,820 47,683
P/E ratio -29.7 x 417 x 110 x 11.1 x 23.2 x 17.9 x
Yield - - - - - -
Capitalization / Revenue 8.3 x 6.25 x 8.94 x 5.24 x 3.94 x 3.81 x
EV / Revenue 5.86 x 4.63 x 7.56 x 4.5 x 3.26 x 3.13 x
EV / EBITDA -23.1 x 114 x 142 x 19.5 x 12.8 x 12 x
EV / FCF -19.8 x 162 x 174 x -19.8 x -115 x 50.3 x
FCF Yield -5.04% 0.62% 0.57% -5.06% -0.87% 1.99%
Price to Book 2.25 x 2.32 x 3.32 x 2.28 x 1.88 x 1.85 x
Nbr of stocks (in thousands) 14,379 14,379 14,379 14,379 14,379 14,379
Reference price 2 3,275 3,388 4,950 4,285 3,765 4,030
Announcement Date 19-03-19 20-03-16 21-03-19 22-03-04 23-03-10 24-03-06
1KRW in Million2KRW
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 5,675 7,794 7,957 11,762 13,753 15,215
EBITDA 1 -1,436 317.4 422.6 2,718 3,499 3,968
EBIT 1 -1,924 -398.9 -253.5 2,179 2,849 3,337
Operating Margin -33.9% -5.12% -3.19% 18.53% 20.72% 21.93%
Earnings before Tax (EBT) 1 -1,588 116.7 468.2 3,813 2,442 3,424
Net income 1 -1,588 116.7 468.2 5,542 2,333 3,236
Net margin -27.98% 1.5% 5.88% 47.12% 16.96% 21.27%
EPS 2 -110.4 8.119 45.00 385.4 162.0 225.0
Free Cash Flow 1 -1,676 222.4 345.8 -2,676 -388.6 947.1
FCF margin -29.53% 2.85% 4.35% -22.75% -2.83% 6.23%
FCF Conversion (EBITDA) - 70.05% 81.83% - - 23.87%
FCF Conversion (Net income) - 190.47% 73.86% - - 29.27%
Dividend per Share - - - - - -
Announcement Date 19-03-19 20-03-16 21-03-19 22-03-04 23-03-10 24-03-06
1KRW in Million2KRW
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 13,853 12,619 11,010 8,701 9,317 10,264
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 -1,676 222 346 -2,676 -389 947
ROE (net income / shareholders' equity) -7.3% 0.56% 2.21% 22.9% 8.35% 10.8%
ROA (Net income/ Total Assets) -5.08% -1.05% -0.63% 4.54% 4.99% 5.36%
Assets 1 31,241 -11,149 -74,041 121,980 46,751 60,381
Book Value Per Share 2 1,453 1,458 1,493 1,877 2,006 2,178
Cash Flow per Share 2 199.0 341.0 392.0 427.0 744.0 1,038
Capex 1 213 262 96.4 3,307 2,001 879
Capex / Sales 3.76% 3.36% 1.21% 28.12% 14.55% 5.77%
Announcement Date 19-03-19 20-03-16 21-03-19 22-03-04 23-03-10 24-03-06
1KRW in Million2KRW
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Medical Diagnostic & Testing Equipment

1st Jan change Capi.
ALIGNED GENETICS, INC. Stock Aligned Genetics, Inc.
+10.30% 46.8M
SARTORIUS AG Stock Sartorius AG
-14.68% 18.57B
QUIDELORTHO CORPORATION Stock QuidelOrtho Corporation
-42.65% 2.82B
INNER MONGOLIA FURUI MEDICAL SCIENCE CO., LTD. Stock Inner Mongolia Furui Medical Science Co., Ltd.
+17.00% 1.85B
SHANGHAI MICROPORT EP MEDTECH CO., LTD. Stock Shanghai MicroPort EP MedTech Co., Ltd.
-0.51% 1.66B
BIOTAGE AB Stock Biotage AB
+27.15% 1.23B
SHANGHAI AOHUA PHOTOELECTRICITY ENDOSCOPE CO., LTD. Stock Shanghai AoHua Photoelectricity Endoscope Co., Ltd.
-13.90% 989M
CONTEC MEDICAL SYSTEMS CO.,LTD Stock Contec Medical Systems Co.,Ltd
-21.76% 896M
REVENIO GROUP OYJ Stock Revenio Group Oyj
-2.72% 734M
VAREX IMAGING CORPORATION Stock Varex Imaging Corporation
-22.00% 667M
Medical Diagnostic & Testing Equipment
  1. Stock Market
  2. Equities
  3. A238120 Stock
  4. Financials Aligned Genetics, Inc.